This review offers a framework for Medicaid programs to broadly assess cell and gene therapies, evaluate payment options, and ensure equitable access. Share: Previous Post Systemic Corticosteroids to Prevent Bronchopulmonary Dysplasia Next Post JAMA Pediatrics Related Articles Clinical Practice Guidelines Association of Race/Ethnicity and Social Disadvantage With Autism Prevalence in 7 Million School Children in England Clinical Practice Guidelines Mental Health Care Utilization Among Children and Adolescents Before and During COVID-19 in Ontario Clinical Practice Guidelines JAMA Pediatrics Clinical Practice Guidelines Effect of Screen Time on Recovery From Concussion Clinical Practice Guidelines Nonauthor Collaborator Supplement Added Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment Name * Email * Website Save my name, email, and website in this browser for the next time I comment.